X
ERAS icon

Xponance’s Erasca ERAS Stock Holding History

Xponance’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Buy
19,615
+2,285
+13% +$32.7K ﹤0.01% 1304
2026
Q1 		$280K Buy
17,330
+3,840
+28% +$45.4K ﹤0.01% 1304
2025
Q4 		$50.2K Hold
13,490
– – ﹤0.01% 1523
2025
Q3 		$29.4K Hold
13,490
– – ﹤0.01% 1513
2025
Q2 		$17.1K Buy
13,490
+374
+3% +$501 ﹤0.01% 1501
2025
Q1 		$18K Buy
13,116
+723
+6% +$1.24K ﹤0.01% 1429
2024
Q4 		$31.1K Buy
12,393
+1,103
+10% +$3.02K ﹤0.01% 1419
2024
Q3 		$30.8K Buy
+11,290
New +$31.8K ﹤0.01% 1367

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Xponance's ERAS Position: Q2 2026 in Review

Xponance increased its Erasca (ERAS) stake by 13% in Q2 2026, buying an estimated $32.7K and bringing the position to 19,615 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Xponance first reported a position in ERAS in Q3 2024 and has held it in 8 quarters since. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Xponance held 19,615 shares of Erasca worth $359K as of Q2 2026.
  • Xponance bought 2,285 Erasca shares in Q2 2026, an estimated $32.7K.
  • Erasca made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1304 holding.
  • Xponance first reported a position in Erasca in Q3 2024 and has held it in 8 quarters since.
  • 257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.